Publications by authors named "Xuejin Lu"

Claim this Profile
D
Discovery of crystalline FeO in returned lunar soils.
Yiheng Liu, Haijun Cao, Rui Li, Jian Chen, Chengxiang Yin, Xuejin Lu, Ying-Bo Lu

Sci Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A narrative review of epigenetic marker in H3K27ac and its emerging potential as a therapeutic target in cancer.
Meizi Zhu, Xuejin Lu, Danhong Wang, Jinhu Ma, Yi Wang

Epigenomics· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Super-enhancers in hepatocellular carcinoma: regulatory mechanism and therapeutic targets.
Xuejin Lu, Meizi Zhu, Xingyue Pei, Jinhu Ma, Rui Wang

Cancer Cell Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microphase iron particle growth promoted by solar wind implantation in lunar soils.
Xuejin Lu, Jian Chen, Haijun Cao, Xiaohui Fu, Xiaojia Zeng

PNAS Nexus· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic regulation of key gene of PCK1 by enhancer and super-enhancer in the pathogenesis of fatty liver hemorrhagic syndrome.
Yi Wang, Shuwen Chen, Min Xue, Jinhu Ma, Xinrui Yi, Xuejin Lu

Anim Biosci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the CDH18 gene associated with age-related macular degeneration using weighted gene co-expression network analysis.
Guina Liu, Mingqi Tan, Rui Liu, Xuejin Lu, Xiaoshuang Jiang, Fang Lu

Front Genet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets.
Xinyu Li, Maozhang He, Xinrui Yi, Xuejin Lu, Meizi Zhu

Heliyon· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of triggers lipid metabolic disorder through H3K27 acetylation-mediated C/EBPβ- activation in non-alcoholic fatty liver disease.
Ya-Ling Zhu, Lei-Lei Meng, Jin-Hu Ma, Xin Yuan, Shu-Wen Chen, Xue-Jin Lu

Zool Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic association study uncovered H3K27 acetylation enhancers and dysregulated genes in high-fat-diet-induced nonalcoholic fatty liver disease in rats.
Jinhu Ma, Dandan You, Shuwen Chen, Nana Fang, Xinrui Yi, Xuejin Lu

Epigenomics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis